HireVue: Two in Five Job-Seekers are Being Hired into New Roles with the Wrong Soft Skills to be Successful
As the battle for talent wages on, two-fifths of job-seekers are being hired into new roles only to discover they have the wrong soft skills for the job, and over half (53%) are leaving companies because their personality or work style didn’t fit. So say the results of new research commissioned by HireVue, provider of the most comprehensive AI-driven talent assessment suite and video interviewing solutions, which sought to examine the current state of pre-hire assessments and the impact they are having on talent acquisition.
With 53% of those who had left for this reason saying the format of the hiring process had prevented them from discovering the mismatch earlier, the research – which questioned over 2,500 job-seekers across Europe and the US – revealed that companies’ current approach to pre-hire assessments leaves much to be desired. This offers recruitment professionals a golden opportunity to deliver a more positive experience and better match candidates’ innate skills and abilities to the roles they are trying to fill.
Further key findings from the research include:
- Question of confidence: While four-fifths (82%) of candidates are confident in their ability to articulate their soft skills and personality traits in an interview, many doubt that pre-hire assessments can showcase these important attributes. Of those who have taken a pre-hire assessment, or have some understanding of what such tests entail, over a third question their ability to measure personality traits (37%) or soft skills (35%). A worrying 41% are also less than certain that pre-hire assessments can gauge potential.
- Fulfilling their potential: Over four in ten (43%) candidates see potential as extremely important or critical to employers when hiring – more so than prior experience, academic achievements, or soft skills. Three quarters (76%) of respondents also stated that they would prefer to be judged on their potential versus their previous experience.
The research also highlighted clear room for improvement in the experience of taking pre-hire assessments:
- Less complexity: Only two fifths found their assessment to be straightforward (42%) and/or professional (39%)
- Quicker process: Nearly a third (30%) of respondents were concerned about the length of time pre-hire assessments take to complete – with length given as the number one reason over a quarter (26%) had dropped out of an assessment before it had finished
- More responsiveness: On average, candidates received feedback on their pre-hire assessments less than half the time (48%), if at all, and it took two days to arrive
“This study demonstrates a real urgency for organizations to reimagine their approach to identifying and retaining the best talent for the job,” said Clemens Aichholzer, Senior Vice President of Game-Based Assessments, HireVue. “This becomes even more critical when you consider that candidates are often customers, and their interaction in the hiring process will impact how they engage with the brand in the future. Indeed, according to our research, over a quarter will engage more with the company on a personal level after a positive assessment experience.
“At the moment, organizations clearly aren’t assessing for the right attributes, and that is setting candidates up for failure later on. Companies should consider more modern assessment methods such as scientifically-designed games and video interviews, which contribute to a faster, more candidate-centric application process but are also extremely effective at predicting an applicant’s potential and matching him or her to the right job. This benefits everybody: recruitment leaders can cast a wider net and then choose from a better qualified and more diverse pool of applicants; candidates feel valued and engaged throughout the hiring process; and organizations boost their bottom line by finding talent that will thrive, while minimizing churn.”
Vanson Bourne, the research firm that conducted the survey, interviewed 2,500 job seekers in the following countries: the UK, US, France and Germany (500 respondents in UK, France and Germany, and 1,000 in the US). For the purposes of this research, pre-hire assessments apply to multiple choice questionnaires, personality tests, situational judgment tests, written tests, job trials, presentations, assessment centres, game-based challenges, video interviews, and technical coding challenges. Fieldwork was conducted in September/October 2018.
Across the globe, HireVue is transforming the way companies discover, hire and develop the best talent with Hiring Intelligence and its HireVue Video Interviewing platform. Using a combination of validated industrial/organizational science and rigorously tested, predictive artificial intelligence, recruiting experts are hiring higher quality talent, faster. HireVue is available worldwide in over 30 languages and has hosted more than eight million on-demand interviews for more than 700 customers worldwide, including over one-third of the Fortune 100 and leading brands such as Vodafone, Intel, Hilton, HealthSouth, Qantas and Carnival Cruise Lines. For more information, visit www.hirevue.com.
HireVue Social Networks
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Tilaa tiedotteet sähköpostiisi
Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.
Lue lisää julkaisijalta Business Wire
AURAK Gains SACSCOC Accreditation15.12.2018 13:49 | Tiedote
The Southern Association of Colleges and Schools Commission on Colleges (SACSCOC) officially announced the accreditation of the American University of Ras Al Khaimah (AURAK) at its 2018 Annual Meeting which was held in New Orleans, Louisiana, in the United States of America. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181215005017/en/ AURAK delegation during the SACSCOC conference in New Orleans” (Photo: AETOSWire) SACSCOC, the regional body for the accreditation of degree-granting higher education institutions in the Southern United States, has a membership of more than 800 institutions in the Southern states and other international sites approved by SACSCOC that award associate, baccalaureate, master’s, and/or doctoral degrees. SACSCOC also awards accreditation to other international institutions of higher education that satisfy all its requirements and demonstrate compliance with its accreditation standards. AURAK now
Lehman Brothers Treasury Announces Plans for Partial Wind-Down14.12.2018 20:41 | Tiedote
Lehman Brothers Treasury Co. B.V. in liquidation (“LBT”) today, through its U.S. counsel Kramer Levin Naftalis & Frankel LLP, announced that LBT is planning a final cash distribution to its creditors. Professional holders of eligible notes will have the option to retain their investment by electing to receive substitute notes of one (or a few) series. Such election shall take place through a solicitation process. As a consequence, LBT will be able to reduce the number of series of notes outstanding from more than 3,700 to one or a few. Noteholders electing to receive substitute notes will be afforded the same economic entitlement to distributions received by LBT from Lehman Brothers Holdings Inc. (“LBHI”) through the substitute notes. The substitute notes will be denominated in U.S. dollars and future distributions will be made in U.S. dollars only. Noteholders who are not professional investors, or hold notes that are not eligible for substitution, or do not elect to receive substitut
Takeda Receives Positive CHMP Opinion for ADCETRIS® (brentuximab vedotin) for the Treatment of Adult Patients with Previously Untreated CD30+ Stage IV Hodgkin Lymphoma in Combination with AVD14.12.2018 20:00 | Tiedote
Takeda Pharmaceutical Company Limited (TSE: 4502) today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for the extension of the marketing authorization of ADCETRIS (brentuximab vedotin) and recommended its approval in combination with AVD in adult patients with previously untreated CD30+ Stage IV Hodgkin lymphoma. ADCETRIS is an antibody-drug conjugate (ADC) directed at CD30, a defining marker of Hodgkin lymphoma. ADCETRIS is currently not approved as a therapy for previously untreated Hodgkin lymphoma in Europe. “For a large number of previously untreated Hodgkin lymphoma patients diagnosed with Stage IV disease, progression will occur with current treatments, highlighting a true unmet need in this population,” said Anna Sureda, M.D., Ph.D., Head of the Hematology Department and Hematopoietic Stem Cell Transplant Programme, Institut Català d'Oncologia - Hospital Duran i Reynals. “In the ECHELON-1 cl
Diamond CBD, POTN Subsidiary, Enters the $46 Billion Coffee Market With the Release of Premium Line of CBD-Infused Coffee & Tea K-Kup Capsules14.12.2018 18:42 | Tiedote
Diamond CBD Inc., wholly owned subsidiary of PotNetwork Holdings, Inc. (OTC Pink: POTN), a leader in hemp extraction and innovative CBD products for the wellness market, enters the Coffee segment, an industry expected to reach revenues of $46 Billion in 2018. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20181214005308/en/ Experience a cup of Chill (Photo: Business Wire) Produced in accordance with a universal K-Cup design, these pods fit in almost all modern single cup coffee makers, making it an easily integrated enhancement to any environment, delivering 25mgs of CBD in a tasty favorite beverage at less than $5 per cup. This new line of premium Chill Coffee Capsules was recently added to the Company’s broad range of cannabinoid and natural hemp products. Each box comes with 4 individual capsules in original chill coffee, decaf chill coffee, chill black tea, and chill green tea flavors. The unit price for each box is $10.00
Henley & Partners Enlarges Executive Committee to Manage Expansion and Growth14.12.2018 17:00 | Tiedote
Residence- and citizenship-by-investment programs have firmly established themselves over the past few years as the new frontier in terms of freedom, flexibility, and future-readiness, both for the countries issuing these programs and for the individual investors participating in them. The societal and economic value these programs generate is undisputed. The investment migration industry as a whole is currently grossing roughly USD 18 billion per year, with an expectation that it will hit the USD 20 billion mark very soon. Foreign direct investment (FDI) is now considered the lifeblood of economic growth for many developing and recovering smaller countries around the world. As such, the number of investment migration programs has been increasing rapidly, from just a handful of programs in the 1980s and 1990s to over 100 countries that now have investment migration provisions in their laws. There are more than 60 active programs today, with Moldova and Montenegro — both fast-growing Eu
Vargatef® plus docetaxel could be an option after failure of immunotherapy in lung cancer14.12.2018 12:07 | Tiedote
Boehringer Ingelheim announced today the first interim results of VARGADO, an ongoing non-interventional study in routine clinical practice in Germany evaluating the efficacy and safety of Vargatef® (nintedanib) and docetaxel in patients with stage III/IV locally advanced or metastatic non-small cell lung cancer (NSCLC) of adenocarcinoma histology. The study consists of three cohorts, two of which allow for prior treatment with immune checkpoint inhibitors (ICIs) either in combination with chemotherapy in the first-line or as monotherapy in the second-line of treatment. The interim results from Cohort B (first-line chemotherapy, second-line immune checkpoint inhibitors, third-line Vargatef® plus docetaxel) were presented today at ESMO Immuno-Oncology Congress 2018 in Geneva.1 Despite a limited sample size, the VARGADO study adds to the body of evidence for nintedanib in lung adenocarcinoma following pre-treatment with chemotherapy and ICIs.1,3 The addition of nintedanib to docetaxel ha
Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.Tutustu uutishuoneeseemme